There is 1 paper on multifocal electroretinography N1-P1 response density in aging research: 1 trial in people.
1 paper studies it1 finding
See all 1 papers on multifocal electroretinography N1-P1 response density
- Human trial1
Interventions
1UBX1325
upin humans1
1 study
UBX1325
upin humans1
UBX1325 increases multifocal electroretinography N1-P1 response density in neovascular AMD subjects with prior anti-VEGF injections (≥20% gain in three of five subjects at Week 8).
“After foselutoclax treatment, the largest improvement in the mfERG N1-P1 response density occurred at Week 8 as three of five subjects achieved a ≥20% gain.”
Human trialin neovascular AMD subjects with prior anti-VEGF injectionsretina50 μL intravitreal injectionn = 5
Journal of clinical medicine
Latest
Journal of Clinical Medicine
Multifocal Electroretinography Changes after UBX1325 (Foselutoclax) Treatment in Neovascular Age-Related Macular Degeneration
Non-randomized trial in 5 peopleNeovascular age-related macular degeneration